Identification of a selective small molecule inhibitor of breast cancer stem cells
Authors:
- Leigh C. CarmodyLCLeigh C. Carmody
- Barbara MorganBMBarbara Morgan
- Cristina FernandezCFCristina Fernandez
- Erin ForbeckEFErin Forbeck
- Timothy A. LewisTLTimothy A. Lewis
- Partha P. NagPNPartha P. Nag
- Amal TingATAmal Ting
- Lynn VerPlankLVLynn VerPlank
- Yuxiong FengYFYuxiong Feng
- Jose R. PerezJPJose R. Perez
- Sivaraman DandapaniSDSivaraman Dandapani
- 1 May 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (10) , 3571-3574
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and AngiogenesisJournal of Clinical Oncology, 2008
- Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse modelBreast Cancer Research and Treatment, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to ChemotherapyJNCI: Journal of the National Cancer Institute, 2008
- NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cellsBreast Cancer Research and Treatment, 2007
- Cancer Stem Cells and Radiotherapy: New Insights Into Tumor RadioresistanceJNCI: Journal of the National Cancer Institute, 2006
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsGenes & Development, 2003